Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 316

Similar articles for PubMed (Select 19180343)

1.

Noncigarette forms of tobacco use.

Viegas CA.

J Bras Pneumol. 2008 Dec;34(12):1069-73. Review. English, Portuguese.

2.

Nasal snuff: historical review and health related aspects.

Sapundzhiev N, Werner JA.

J Laryngol Otol. 2003 Sep;117(9):686-91.

PMID:
14561353
3.

[Risk reduction strategies in smoking].

Martinet Y, Bohadana A, Wirth N, Spinosa A, Béguinot E.

Rev Mal Respir. 2006 Sep;23(4 Suppl):13S109-18; quiz 13S158, 13S159. French.

PMID:
17057636
4.

Dissent over harm reduction for tobacco.

Gray N, Henningfield J.

Lancet. 2006 Sep 9;368(9539):899-901. No abstract available.

PMID:
16962864
5.

Tobacco smoking, harm reduction, and nicotine product regulation.

Britton J, Edwards R.

Lancet. 2008 Feb 2;371(9610):441-5. Epub 2007 Oct 24. Review. No abstract available.

PMID:
17920116
6.

Snuff, nicotine and cardiovascular disease: implications for tobacco control.

Benowitz NL.

J Am Coll Cardiol. 1999 Nov 15;34(6):1791-3. No abstract available.

PMID:
10577571
7.

Smokeless tobacco: the health consequences of snuff and chewing tobacco.

Goolsby MJ.

Nurse Pract. 1992 Jan;17(1):24, 28, 31, passim. Review.

PMID:
1538836
8.

Metabolic and cardiovascular effects of smokeless tobacco.

Arabi Z.

J Cardiometab Syndr. 2006 Fall;1(5):345-50. Review.

PMID:
17679792
9.

Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels.

Gyllén P, Andersson BA, Qvarfordt I.

Respir Med. 2004 Feb;98(2):108-14.

PMID:
14971872
10.

Smokeless tobacco: an addicting drug.

Henningfield JE, Fant RV, Tomar SL.

Adv Dent Res. 1997 Sep;11(3):330-5. Review.

PMID:
9524433
11.

Tobacco product regulation: context and issues.

Slade J, Henningfield JE.

Food Drug Law J. 1998;53 suppl:43-74. No abstract available.

PMID:
10342980
12.

Chronic nicotine effects on left ventricular function in healthy middle-aged people: an echocardiographic study.

Sundström D, Waldenborg M, Magnuson A, Emilsson K.

Clin Physiol Funct Imaging. 2013 Jul;33(4):317-24. doi: 10.1111/cpf.12031. Epub 2013 Feb 25.

PMID:
23692623
13.
14.

Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects.

Berggren U, Eriksson M, Fahlke C, Blennow K, Balldin J.

Alcohol Alcohol. 2007 May-Jun;42(3):267-71.

15.

[Use of snuff entails lower risk of cardiovascular diseases than does smoking].

Asplund K.

Lakartidningen. 2003 Jun 19;100(25):2206-10. Review. Swedish.

PMID:
12872508
16.

Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study.

Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D.

Cancer. 2007 Jun 15;109(12):2547-56.

17.

Alternative forms of tobacco use.

Prignot JJ, Sasco AJ, Poulet E, Gupta PC, Aditama TY.

Int J Tuberc Lung Dis. 2008 Jul;12(7):718-27.

PMID:
18544194
18.
19.

Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.

Richter P, Hodge K, Stanfill S, Zhang L, Watson C.

Nicotine Tob Res. 2008 Nov;10(11):1645-52. doi: 10.1080/14622200802412937.

PMID:
18988077
20.

Smokeless tobacco and cardiovascular risk.

Gupta R, Gurm H, Bartholomew JR.

Arch Intern Med. 2004 Sep 27;164(17):1845-9. Review.

PMID:
15451758
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk